Older womens views about prescription osteoporosis medication: A cross-sectional, qualitative study

Drugs and Aging

Volumn 27, Issue 12, 2010, Pages 999-1008

  Mazor, Kathleen M ^a,b,c,d   Velten, Sarah ^a,b,c,d   Andrade, Susan E ^a,b,c,d   Yood, Robert A ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Fallon Clinic   (United States)

^d Fallon Community Health Plan   (United States)

Author keywords

Elderly; Menopause; Osteoporosis, prevention; Osteoporosis, treatment; Osteoporosis therapies, therapeutic use; Patient compliance.

Indexed keywords

AGED; ARTICLE; BONE MASS; CROSS-SECTIONAL STUDY; DRUG SAFETY; DRUG USE; FEMALE; HEALTH BEHAVIOR; HEALTH BELIEF; HUMAN; INTERVIEW; OSTEOPOROSIS; PATIENT ATTITUDE; PERSONAL EXPERIENCE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; QUALITATIVE RESEARCH; TELEPHONE; AGE; BONE DENSITY; COMPARATIVE STUDY; DRUG EFFECT; PATIENT PREFERENCE; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; PSYCHOLOGICAL ASPECT; SEX DIFFERENCE; STANDARD;

PRESCRIPTION DRUG;

AGE FACTORS; AGED; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERVIEWS AS TOPIC; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT PREFERENCE; PRESCRIPTION DRUGS; SEX FACTORS; WOMEN;

EID: 78649385824     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11584790-000000000-00000     Document Type: Article

References (19)

1. National Osteoporosis Foundation. Fast factson osteoporosis [online]. Available from URL: http://www.nof.org/osteo porosis/diseasefacts.htm [Accessed 2010 Feb 04]
2. Siris ES, Selby PL, Saag KG, et al. Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med 2009 Feb; 122 (2 Suppl.): S3-13
3. Siris ES, Harris ST, Rosen CJ, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 2006 Aug; 81 (8): 1013-22
4. Caro JJ, Ishak KJ, Huybrechts KF, et al. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 2004 Dec; 15 (12): 1003-8
5. Huybrechts KF, Ishak KJ, Caro JJ. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone 2006 Jun; 38 (6): 922-8
6. Penning-van Beest FJ, Erkens JA, Olson M, et al. Loss of treatment benefit due to low compliance with bisphos-phonate therapy. Osteoporos Int 2008 Apr; 19 (4): 511-7
7. Gallagher AM, Rietbrock S, Olson M, et al. Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res 2008 Oct; 23 (10): 1569-75
8. Yood RA, Emani S, Reed JI, et al. Compliance with pharmacologic therapy for osteoporosis. Osteoporos Int 2003 Dec; 14 (12): 965-8
9. Yood RA, Mazor KM, Andrade SE, et al. Patient decision to initiate therapy for osteoporosis: the influenceof knowledge and beliefs. J Gen Intern Med 2008 Nov; 23 (11): 1815-21
10. Solomon DH, Avorn J, Katz JN, et al. Compliance with osteoporosis medications. Arch Intern Med 2005 Nov 14; 165 (20): 2414-9
11. Papaioannou A, Kennedy CC, Dolovich L, et al. Patient adherence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging 2007; 24 (1): 37-55
12. Tosteson AN, Grove MR, Hammond CS, et al. Early discontinuation of treatment for osteoporosis. Am J Med 2003 Aug; 115 (3): 209-16
13. McCombs JS, Thiebaud P, McLaughlin-Miley C, et al. Compliance with drug therapies for the treatment and preventionof osteoporosis. Maturitas 2004 Jul;48(3): 271-87
14. Briesacher BA, Andrade SE, Yood RA, et al. Consequences of poor compliance with bisphosphonates. Bone 2007 Nov; 41 (5): 882-7
15. Sunyecz JA, Mucha L, Baser O, et al. Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization. Osteoporos Int 2008 Oct; 19 (10): 1421-9
16. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff (Millwood) 2005 Jan-Jun; Suppl. Web Ex-clusives: W5-152-W5-66
17. McHorney CA, Schousboe JT, Cline RR, et al. The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates. Curr Med Res Opin 2007 Dec; 23 (12): 3137-52
18. Johnson MJ. The medication adherence model: a guide for assessing medication taking. Res Theory Nurs Pract 2002 Fall; 16 (3): 179-92
19. Janz N, Champion V, Strecher V. The health belief model. In: Glanz K, Rimer B, Lewis F, editors. Health behavior and health education. 3rd ed. San Francisco (CA): Jossey-Bass, 2002: 45-66